

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.64787129 |
| 2 | negative regulation of cell killing (GO:0031342) | 4.64787129 |
| 3 | sperm motility (GO:0030317) | 4.55547229 |
| 4 | complement activation, alternative pathway (GO:0006957) | 4.51064769 |
| 5 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.44967877 |
| 6 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.44348764 |
| 7 | L-phenylalanine catabolic process (GO:0006559) | 4.44348764 |
| 8 | fusion of sperm to egg plasma membrane (GO:0007342) | 4.37624953 |
| 9 | alpha-linolenic acid metabolic process (GO:0036109) | 4.36760390 |
| 10 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.31233584 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.30253810 |
| 12 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.14719122 |
| 13 | L-phenylalanine metabolic process (GO:0006558) | 4.13399628 |
| 14 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.13399628 |
| 15 | regulation of protein activation cascade (GO:2000257) | 4.12849248 |
| 16 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.09397730 |
| 17 | regulation of complement activation (GO:0030449) | 4.06008847 |
| 18 | acrosome reaction (GO:0007340) | 4.05797691 |
| 19 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.02668671 |
| 20 | protein carboxylation (GO:0018214) | 4.02668671 |
| 21 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.95771960 |
| 22 | neutrophil activation involved in immune response (GO:0002283) | 3.93458855 |
| 23 | response to peptidoglycan (GO:0032494) | 3.87739188 |
| 24 | cilium or flagellum-dependent cell motility (GO:0001539) | 3.86067911 |
| 25 | positive regulation by symbiont of host defense response (GO:0052509) | 3.83039156 |
| 26 | modulation by symbiont of host defense response (GO:0052031) | 3.83039156 |
| 27 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.83039156 |
| 28 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.83039156 |
| 29 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.83039156 |
| 30 | modulation by symbiont of host immune response (GO:0052553) | 3.83039156 |
| 31 | macrophage activation involved in immune response (GO:0002281) | 3.78716050 |
| 32 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.78184972 |
| 33 | negative regulation of fibrinolysis (GO:0051918) | 3.72275199 |
| 34 | detection of other organism (GO:0098543) | 3.69360048 |
| 35 | detection of bacterium (GO:0016045) | 3.69038095 |
| 36 | negative regulation of interleukin-12 production (GO:0032695) | 3.64763109 |
| 37 | immunoglobulin mediated immune response (GO:0016064) | 3.63207114 |
| 38 | aromatic amino acid family catabolic process (GO:0009074) | 3.55372306 |
| 39 | low-density lipoprotein particle clearance (GO:0034383) | 3.53988243 |
| 40 | plasma lipoprotein particle clearance (GO:0034381) | 3.53912629 |
| 41 | bile acid biosynthetic process (GO:0006699) | 3.52287158 |
| 42 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.51094392 |
| 43 | regulation of fibrinolysis (GO:0051917) | 3.41827472 |
| 44 | plasma membrane fusion (GO:0045026) | 3.39961287 |
| 45 | sulfur amino acid catabolic process (GO:0000098) | 3.39774516 |
| 46 | regulation of triglyceride catabolic process (GO:0010896) | 3.37027348 |
| 47 | urea metabolic process (GO:0019627) | 3.35982330 |
| 48 | urea cycle (GO:0000050) | 3.35982330 |
| 49 | opsonization (GO:0008228) | 3.32177912 |
| 50 | cellular response to type I interferon (GO:0071357) | 3.30085211 |
| 51 | type I interferon signaling pathway (GO:0060337) | 3.30085211 |
| 52 | response to type I interferon (GO:0034340) | 3.29959997 |
| 53 | detection of external biotic stimulus (GO:0098581) | 3.29125207 |
| 54 | high-density lipoprotein particle remodeling (GO:0034375) | 3.23893739 |
| 55 | germinal center formation (GO:0002467) | 3.19689209 |
| 56 | acylglycerol homeostasis (GO:0055090) | 3.19315811 |
| 57 | triglyceride homeostasis (GO:0070328) | 3.19315811 |
| 58 | cell wall macromolecule metabolic process (GO:0044036) | 3.13892998 |
| 59 | cell wall macromolecule catabolic process (GO:0016998) | 3.13892998 |
| 60 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.13399046 |
| 61 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.13399046 |
| 62 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.12911739 |
| 63 | fibrinolysis (GO:0042730) | 3.12558340 |
| 64 | acrosome assembly (GO:0001675) | 3.12062934 |
| 65 | NIK/NF-kappaB signaling (GO:0038061) | 3.11417145 |
| 66 | coenzyme catabolic process (GO:0009109) | 3.09872920 |
| 67 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.09014233 |
| 68 | response to muramyl dipeptide (GO:0032495) | 3.08156066 |
| 69 | regulation of mast cell degranulation (GO:0043304) | 3.07634043 |
| 70 | tyrosine metabolic process (GO:0006570) | 3.06649083 |
| 71 | regulation of cholesterol homeostasis (GO:2000188) | 3.05975266 |
| 72 | nitrogen cycle metabolic process (GO:0071941) | 3.05529712 |
| 73 | detection of molecule of bacterial origin (GO:0032490) | 3.04910075 |
| 74 | leukocyte aggregation (GO:0070486) | 3.03418212 |
| 75 | multicellular organism reproduction (GO:0032504) | 3.03241957 |
| 76 | amino-acid betaine metabolic process (GO:0006577) | 3.02943769 |
| 77 | complement activation (GO:0006956) | 3.01304135 |
| 78 | reverse cholesterol transport (GO:0043691) | 2.98051700 |
| 79 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.97138219 |
| 80 | regulation of gamma-delta T cell activation (GO:0046643) | 2.96972791 |
| 81 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.96904539 |
| 82 | * sperm-egg recognition (GO:0035036) | 2.96801273 |
| 83 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.94043341 |
| 84 | kynurenine metabolic process (GO:0070189) | 2.93842618 |
| 85 | complement activation, classical pathway (GO:0006958) | 2.93795296 |
| 86 | bile acid metabolic process (GO:0008206) | 2.92192210 |
| 87 | reproduction (GO:0000003) | 2.91553303 |
| 88 | organic cation transport (GO:0015695) | 2.90687875 |
| 89 | cellular extravasation (GO:0045123) | 2.90047978 |
| 90 | regulation of plasminogen activation (GO:0010755) | 2.89998806 |
| 91 | detection of biotic stimulus (GO:0009595) | 2.88800825 |
| 92 | positive regulation of lipid catabolic process (GO:0050996) | 2.87846482 |
| 93 | regulation of antigen processing and presentation (GO:0002577) | 2.87633322 |
| 94 | tryptophan catabolic process (GO:0006569) | 2.87278842 |
| 95 | indole-containing compound catabolic process (GO:0042436) | 2.87278842 |
| 96 | indolalkylamine catabolic process (GO:0046218) | 2.87278842 |
| 97 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.87119489 |
| 98 | phospholipid efflux (GO:0033700) | 2.86231592 |
| 99 | regulation of leukocyte degranulation (GO:0043300) | 2.85543674 |
| 100 | plasma lipoprotein particle remodeling (GO:0034369) | 2.85495707 |
| 101 | protein-lipid complex remodeling (GO:0034368) | 2.85495707 |
| 102 | macromolecular complex remodeling (GO:0034367) | 2.85495707 |
| 103 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.85470676 |
| 104 | glyoxylate metabolic process (GO:0046487) | 2.84669284 |
| 105 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 2.83198923 |
| 106 | granulocyte activation (GO:0036230) | 2.83028483 |
| 107 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.82679825 |
| 108 | axonemal dynein complex assembly (GO:0070286) | 2.82662528 |
| 109 | neutrophil activation (GO:0042119) | 2.81407339 |
| 110 | positive regulation of antigen processing and presentation (GO:0002579) | 2.81240964 |
| 111 | protein activation cascade (GO:0072376) | 2.80528505 |
| 112 | defense response to protozoan (GO:0042832) | 2.79095347 |
| 113 | negative regulation of protein activation cascade (GO:2000258) | 2.78676890 |
| 114 | macrophage activation (GO:0042116) | 2.76666866 |
| 115 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.75898985 |
| 116 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.75607057 |
| 117 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.75248537 |
| 118 | cofactor catabolic process (GO:0051187) | 2.75182628 |
| 119 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.74925425 |
| 120 | epithelial cilium movement (GO:0003351) | 2.74872391 |
| 121 | negative regulation of innate immune response (GO:0045824) | 2.73734956 |
| 122 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.72556320 |
| 123 | carnitine metabolic process (GO:0009437) | 2.71586667 |
| 124 | regulation of T cell tolerance induction (GO:0002664) | 2.71480060 |
| 125 | cysteine metabolic process (GO:0006534) | 2.71447977 |
| 126 | mannose metabolic process (GO:0006013) | 2.70716329 |
| 127 | cholesterol efflux (GO:0033344) | 2.70511259 |
| 128 | tryptophan metabolic process (GO:0006568) | 2.70296595 |
| 129 | myeloid dendritic cell differentiation (GO:0043011) | 2.69851799 |
| 130 | * cell-cell recognition (GO:0009988) | 2.69461439 |
| 131 | positive regulation of fatty acid oxidation (GO:0046321) | 2.69392049 |
| 132 | epoxygenase P450 pathway (GO:0019373) | 2.67880103 |
| 133 | myeloid cell activation involved in immune response (GO:0002275) | 2.66536731 |
| 134 | spermatid development (GO:0007286) | 2.65376699 |
| 135 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.64436078 |
| 136 | regulation of cholesterol esterification (GO:0010872) | 2.64262115 |
| 137 | response to protozoan (GO:0001562) | 2.62600552 |
| 138 | homocysteine metabolic process (GO:0050667) | 2.61520444 |
| 139 | amino sugar catabolic process (GO:0046348) | 2.60749260 |
| 140 | negative regulation of sterol transport (GO:0032372) | 2.59725729 |
| 141 | negative regulation of cholesterol transport (GO:0032375) | 2.59725729 |
| 142 | positive thymic T cell selection (GO:0045059) | 2.59623485 |
| 143 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.58751945 |
| 144 | negative regulation of interleukin-6 production (GO:0032715) | 2.58162125 |
| 145 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.58146610 |
| 146 | cholesterol homeostasis (GO:0042632) | 2.56499158 |
| 147 | macroautophagy (GO:0016236) | 2.55535856 |
| 148 | regulation of cholesterol storage (GO:0010885) | 2.54936061 |
| 149 | lipoprotein metabolic process (GO:0042157) | 2.54900670 |
| 150 | * binding of sperm to zona pellucida (GO:0007339) | 2.54634846 |
| 151 | fatty acid catabolic process (GO:0009062) | 2.54560802 |
| 152 | tolerance induction (GO:0002507) | 2.54265863 |
| 153 | positive regulation of glycolytic process (GO:0045821) | 2.54144325 |
| 154 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.53733017 |
| 155 | 4-hydroxyproline metabolic process (GO:0019471) | 2.53560809 |
| 156 | T-helper 1 type immune response (GO:0042088) | 2.53289607 |
| 157 | regulation of tolerance induction (GO:0002643) | 2.53133262 |
| 158 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.52694792 |
| 159 | response to host immune response (GO:0052572) | 2.52694792 |
| 160 | sterol homeostasis (GO:0055092) | 2.52633905 |
| 161 | respiratory burst (GO:0045730) | 2.52193205 |
| 162 | fatty-acyl-CoA biosynthetic process (GO:0046949) | 2.52177474 |
| 163 | cellular modified amino acid catabolic process (GO:0042219) | 2.51994891 |
| 164 | fatty acid beta-oxidation (GO:0006635) | 2.51238319 |
| 165 | B cell mediated immunity (GO:0019724) | 2.51193306 |
| 166 | peptidyl-glutamic acid modification (GO:0018200) | 2.50834431 |
| 167 | positive regulation of coagulation (GO:0050820) | 2.50736396 |
| 168 | sexual reproduction (GO:0019953) | 2.50643013 |
| 169 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.50588978 |
| 170 | regulation of lipid catabolic process (GO:0050994) | 2.50405463 |
| 171 | positive regulation of blood coagulation (GO:0030194) | 2.50368356 |
| 172 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.48570686 |
| 173 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.48506999 |
| 174 | myeloid dendritic cell activation (GO:0001773) | 2.46474565 |
| 175 | microglial cell activation (GO:0001774) | 2.46281183 |
| 176 | positive regulation of type 2 immune response (GO:0002830) | 2.44139262 |
| 177 | regulation of chemokine biosynthetic process (GO:0045073) | 2.43662551 |
| 178 | regulation of type 2 immune response (GO:0002828) | 2.43038988 |
| 179 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.42573057 |
| 180 | barbed-end actin filament capping (GO:0051016) | 2.40921810 |
| 181 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.38695774 |
| 182 | virion attachment to host cell (GO:0019062) | 2.38121757 |
| 183 | adhesion of symbiont to host cell (GO:0044650) | 2.38121757 |
| 184 | positive regulation of mast cell activation (GO:0033005) | 2.37845109 |
| 185 | negative regulation of T cell mediated immunity (GO:0002710) | 2.37742252 |
| 186 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.37184733 |
| 187 | response to host (GO:0075136) | 2.35854797 |
| 188 | response to host defenses (GO:0052200) | 2.35854797 |
| 189 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.35854797 |
| 190 | regulation of mast cell activation (GO:0033003) | 2.35782976 |
| 191 | regulation of tumor necrosis factor superfamily cytokine production (GO:1903555) | 2.35509939 |
| 192 | negative regulation of interleukin-8 production (GO:0032717) | 2.35384755 |
| 193 | regulation of interferon-alpha production (GO:0032647) | 2.34711805 |
| 194 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.34548355 |
| 195 | regulation of regulated secretory pathway (GO:1903305) | 2.34515322 |
| 196 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.32714491 |
| 197 | positive regulation of mast cell degranulation (GO:0043306) | 2.31781291 |
| 198 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.31781291 |
| 199 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.31534190 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.73940169 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 4.21071170 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.19210109 |
| 4 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.61320385 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.55980580 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.30791608 |
| 7 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.82264291 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.79327660 |
| 9 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.77419309 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.70792279 |
| 11 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.54008696 |
| 12 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.45505472 |
| 13 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.35705089 |
| 14 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.34550362 |
| 15 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.29757903 |
| 16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.23846116 |
| 17 | * RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.15840468 |
| 18 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.10641881 |
| 19 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.99569887 |
| 20 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.96218129 |
| 21 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.89467551 |
| 22 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.86771807 |
| 23 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.85636826 |
| 24 | MAF_26560356_Chip-Seq_TH1_Human | 1.82618049 |
| 25 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.81012437 |
| 26 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.80567280 |
| 27 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.79955370 |
| 28 | SPI1_23127762_ChIP-Seq_K562_Human | 1.78224624 |
| 29 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.73645313 |
| 30 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.72302739 |
| 31 | UTX_26944678_Chip-Seq_JUKART_Human | 1.71595166 |
| 32 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.68236862 |
| 33 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.67222492 |
| 34 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.67112998 |
| 35 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.67081108 |
| 36 | MYC_22102868_ChIP-Seq_BL_Human | 1.67046297 |
| 37 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.66462668 |
| 38 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.57515830 |
| 39 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.54213137 |
| 40 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.54158958 |
| 41 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.52237040 |
| 42 | MAF_26560356_Chip-Seq_TH2_Human | 1.51974628 |
| 43 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.51902851 |
| 44 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.48588710 |
| 45 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.48368985 |
| 46 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.48144561 |
| 47 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.45619260 |
| 48 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.45321789 |
| 49 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.45091368 |
| 50 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.42998906 |
| 51 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.40782662 |
| 52 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.39059680 |
| 53 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.37418983 |
| 54 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.37383032 |
| 55 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.35113301 |
| 56 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.34925614 |
| 57 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.34727491 |
| 58 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.34066651 |
| 59 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.32734649 |
| 60 | P68_20966046_ChIP-Seq_HELA_Human | 1.32368176 |
| 61 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.30535825 |
| 62 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.30505302 |
| 63 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.28647846 |
| 64 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.25631532 |
| 65 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.24380999 |
| 66 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.22437219 |
| 67 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.21800490 |
| 68 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.21630967 |
| 69 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.19273585 |
| 70 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.18894303 |
| 71 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.18035241 |
| 72 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.16693138 |
| 73 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.16493642 |
| 74 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.16350834 |
| 75 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.16141051 |
| 76 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.15679912 |
| 77 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.15309362 |
| 78 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.14370051 |
| 79 | * MYB_26560356_Chip-Seq_TH2_Human | 1.13717686 |
| 80 | * SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12973248 |
| 81 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.12817220 |
| 82 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.11899822 |
| 83 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.10981251 |
| 84 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.10659279 |
| 85 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.10627825 |
| 86 | MYB_26560356_Chip-Seq_TH1_Human | 1.10099175 |
| 87 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.09249387 |
| 88 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.08838347 |
| 89 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08264465 |
| 90 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.06890063 |
| 91 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.06405462 |
| 92 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.06342879 |
| 93 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.05924377 |
| 94 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.05902418 |
| 95 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.05733156 |
| 96 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.05733156 |
| 97 | SA1_27219007_Chip-Seq_Bcells_Human | 1.03563805 |
| 98 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.03546812 |
| 99 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.99353631 |
| 100 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.98036745 |
| 101 | CJUN_26792858_Chip-Seq_BT549_Human | 0.97830310 |
| 102 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.97677271 |
| 103 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97272533 |
| 104 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.97183156 |
| 105 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.96763450 |
| 106 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.95214482 |
| 107 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.93686035 |
| 108 | EZH2_22144423_ChIP-Seq_EOC_Human | 0.93122028 |
| 109 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.92035553 |
| 110 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.90289915 |
| 111 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.90289915 |
| 112 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.90134636 |
| 113 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.89414619 |
| 114 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89027643 |
| 115 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.88374434 |
| 116 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.88282775 |
| 117 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.86111353 |
| 118 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.84624937 |
| 119 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.84116572 |
| 120 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.83214476 |
| 121 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.81966660 |
| 122 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.81625788 |
| 123 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.81281905 |
| 124 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.81200986 |
| 125 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.80656792 |
| 126 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.80585453 |
| 127 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.80107080 |
| 128 | GATA1_19941826_ChIP-Seq_K562_Human | 0.79528458 |
| 129 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.78922327 |
| 130 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.78778580 |
| 131 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.77911728 |
| 132 | P53_21459846_ChIP-Seq_SAOS-2_Human | 0.77830966 |
| 133 | * CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.77411904 |
| 134 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.77335391 |
| 135 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.77248550 |
| 136 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.77247481 |
| 137 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.76312934 |
| 138 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.75706084 |
| 139 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.75533719 |
| 140 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.74951959 |
| 141 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.74692791 |
| 142 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 0.74395186 |
| 143 | EBNA1_20929547_Chip-Seq_RAJI-cells_Human | 0.74252489 |
| 144 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 0.74109000 |
| 145 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.73992516 |
| 146 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.73295483 |
| 147 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.73243012 |
| 148 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.73163099 |
| 149 | GATA2_19941826_ChIP-Seq_K562_Human | 0.72970242 |
| 150 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.72944133 |
| 151 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.71658677 |
| 152 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 0.71463586 |
| 153 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.71299361 |
| 154 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.71272094 |
| 155 | * BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.71204626 |
| 156 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.70231069 |
| 157 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.69798672 |
| 158 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.69622507 |
| 159 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.69074712 |
| 160 | KDM2B_26808549_Chip-Seq_K562_Human | 0.68404379 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005410_abnormal_fertilization | 5.01385001 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 4.68681337 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 4.67243317 |
| 4 | MP0005360_urolithiasis | 4.08087101 |
| 5 | MP0005365_abnormal_bile_salt | 3.51849101 |
| 6 | MP0005085_abnormal_gallbladder_physiolo | 3.49484202 |
| 7 | MP0001835_abnormal_antigen_presentation | 2.93318316 |
| 8 | MP0003252_abnormal_bile_duct | 2.86951988 |
| 9 | MP0005275_abnormal_skin_tensile | 2.77530889 |
| 10 | MP0008875_abnormal_xenobiotic_pharmacok | 2.75103659 |
| 11 | MP0003705_abnormal_hypodermis_morpholog | 2.71876891 |
| 12 | MP0002419_abnormal_innate_immunity | 2.67612829 |
| 13 | MP0009840_abnormal_foam_cell | 2.60100930 |
| 14 | MP0005025_abnormal_response_to | 2.57497627 |
| 15 | MP0009785_altered_susceptibility_to | 2.54897885 |
| 16 | MP0010329_abnormal_lipoprotein_level | 2.53288148 |
| 17 | MP0005000_abnormal_immune_tolerance | 2.50201923 |
| 18 | MP0005503_abnormal_tendon_morphology | 2.49614628 |
| 19 | MP0001790_abnormal_immune_system | 2.45238330 |
| 20 | MP0005387_immune_system_phenotype | 2.45238330 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 2.43733520 |
| 22 | MP0000685_abnormal_immune_system | 2.34492236 |
| 23 | MP0005671_abnormal_response_to | 2.34390029 |
| 24 | MP0003191_abnormal_cellular_cholesterol | 2.27891702 |
| 25 | MP0001800_abnormal_humoral_immune | 2.17715307 |
| 26 | MP0005058_abnormal_lysosome_morphology | 2.17360840 |
| 27 | MP0005670_abnormal_white_adipose | 2.10746591 |
| 28 | MP0002723_abnormal_immune_serum | 2.08327296 |
| 29 | MP0002452_abnormal_antigen_presenting | 2.02438014 |
| 30 | MP0003806_abnormal_nucleotide_metabolis | 1.95791277 |
| 31 | MP0002420_abnormal_adaptive_immunity | 1.91586271 |
| 32 | MP0001819_abnormal_immune_cell | 1.90962598 |
| 33 | MP0004510_myositis | 1.88948473 |
| 34 | MP0010155_abnormal_intestine_physiology | 1.88491913 |
| 35 | MP0003279_aneurysm | 1.83452811 |
| 36 | MP0000013_abnormal_adipose_tissue | 1.79622137 |
| 37 | MP0009278_abnormal_bone_marrow | 1.74156180 |
| 38 | MP0005451_abnormal_body_composition | 1.72974754 |
| 39 | * MP0002118_abnormal_lipid_homeostasis | 1.72709492 |
| 40 | MP0005083_abnormal_biliary_tract | 1.72329854 |
| 41 | MP0003195_calcinosis | 1.69349567 |
| 42 | MP0001845_abnormal_inflammatory_respons | 1.66872044 |
| 43 | MP0002405_respiratory_system_inflammati | 1.65301732 |
| 44 | MP0008260_abnormal_autophagy | 1.62582294 |
| 45 | MP0000609_abnormal_liver_physiology | 1.55875812 |
| 46 | MP0005623_abnormal_meninges_morphology | 1.55608223 |
| 47 | MP0003724_increased_susceptibility_to | 1.54395749 |
| 48 | MP0006054_spinal_hemorrhage | 1.53241413 |
| 49 | MP0002295_abnormal_pulmonary_circulatio | 1.53041653 |
| 50 | MP0009333_abnormal_splenocyte_physiolog | 1.52359784 |
| 51 | MP0010368_abnormal_lymphatic_system | 1.52049666 |
| 52 | MP0003172_abnormal_lysosome_physiology | 1.51444053 |
| 53 | MP0004272_abnormal_basement_membrane | 1.49688948 |
| 54 | MP0000858_altered_metastatic_potential | 1.43937990 |
| 55 | MP0003763_abnormal_thymus_physiology | 1.43288564 |
| 56 | MP0000604_amyloidosis | 1.41698428 |
| 57 | MP0005332_abnormal_amino_acid | 1.41650744 |
| 58 | MP0003329_amyloid_beta_deposits | 1.39832150 |
| 59 | MP0003690_abnormal_glial_cell | 1.38236572 |
| 60 | MP0000343_altered_response_to | 1.37774520 |
| 61 | * MP0000716_abnormal_immune_system | 1.36685914 |
| 62 | MP0009384_cardiac_valve_regurgitation | 1.35271749 |
| 63 | MP0003183_abnormal_peptide_metabolism | 1.31730261 |
| 64 | MP0000465_gastrointestinal_hemorrhage | 1.30856329 |
| 65 | MP0005397_hematopoietic_system_phenotyp | 1.29617596 |
| 66 | MP0001545_abnormal_hematopoietic_system | 1.29617596 |
| 67 | MP0001958_emphysema | 1.28940402 |
| 68 | MP0003075_altered_response_to | 1.28201955 |
| 69 | MP0004130_abnormal_muscle_cell | 1.24214523 |
| 70 | MP0005166_decreased_susceptibility_to | 1.23677942 |
| 71 | MP0002060_abnormal_skin_morphology | 1.22244328 |
| 72 | MP0002398_abnormal_bone_marrow | 1.21837302 |
| 73 | MP0005319_abnormal_enzyme/_coenzyme | 1.19887095 |
| 74 | MP0003828_pulmonary_edema | 1.17768176 |
| 75 | MP0005310_abnormal_salivary_gland | 1.14270073 |
| 76 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.13913678 |
| 77 | MP0003866_abnormal_defecation | 1.13351654 |
| 78 | MP0001533_abnormal_skeleton_physiology | 1.12394187 |
| 79 | MP0001666_abnormal_nutrient_absorption | 1.09483680 |
| 80 | MP0001873_stomach_inflammation | 1.07000678 |
| 81 | MP0001851_eye_inflammation | 1.06276170 |
| 82 | MP0008004_abnormal_stomach_pH | 1.05190826 |
| 83 | MP0003448_altered_tumor_morphology | 1.04717185 |
| 84 | * MP0002429_abnormal_blood_cell | 1.04561287 |
| 85 | MP0003698_abnormal_male_reproductive | 1.04180498 |
| 86 | MP0000689_abnormal_spleen_morphology | 1.02067998 |
| 87 | MP0001663_abnormal_digestive_system | 1.01806616 |
| 88 | MP0002722_abnormal_immune_system | 1.00337726 |
| 89 | MP0002877_abnormal_melanocyte_morpholog | 0.99733712 |
| 90 | MP0000003_abnormal_adipose_tissue | 0.98278586 |
| 91 | MP0006082_CNS_inflammation | 0.96215244 |
| 92 | MP0003436_decreased_susceptibility_to | 0.94907290 |
| 93 | MP0003453_abnormal_keratinocyte_physiol | 0.94581973 |
| 94 | MP0001853_heart_inflammation | 0.94379180 |
| 95 | MP0002132_abnormal_respiratory_system | 0.94002390 |
| 96 | MP0002933_joint_inflammation | 0.92960210 |
| 97 | MP0005375_adipose_tissue_phenotype | 0.90729323 |
| 98 | MP0003300_gastrointestinal_ulcer | 0.89882266 |
| 99 | MP0004883_abnormal_blood_vessel | 0.89423895 |
| 100 | MP0005464_abnormal_platelet_physiology | 0.88872995 |
| 101 | MP0002971_abnormal_brown_adipose | 0.88655926 |
| 102 | MP0003868_abnormal_feces_composition | 0.88227788 |
| 103 | MP0005334_abnormal_fat_pad | 0.88019537 |
| 104 | MP0002896_abnormal_bone_mineralization | 0.87007059 |
| 105 | MP0009643_abnormal_urine_homeostasis | 0.86742619 |
| 106 | MP0001849_ear_inflammation | 0.86358878 |
| 107 | MP0004858_abnormal_nervous_system | 0.86339262 |
| 108 | MP0004019_abnormal_vitamin_homeostasis | 0.85899476 |
| 109 | MP0000598_abnormal_liver_morphology | 0.85679891 |
| 110 | MP0002090_abnormal_vision | 0.85344900 |
| 111 | MP0000249_abnormal_blood_vessel | 0.84690648 |
| 112 | MP0005167_abnormal_blood-brain_barrier | 0.84331621 |
| 113 | MP0005164_abnormal_response_to | 0.83556380 |
| 114 | MP0009780_abnormal_chondrocyte_physiolo | 0.83500447 |
| 115 | MP0003795_abnormal_bone_structure | 0.82110589 |
| 116 | MP0005666_abnormal_adipose_tissue | 0.81071109 |
| 117 | MP0002138_abnormal_hepatobiliary_system | 0.78997261 |
| 118 | MP0005535_abnormal_body_temperature | 0.77536370 |
| 119 | MP0008874_decreased_physiological_sensi | 0.77443358 |
| 120 | MP0005023_abnormal_wound_healing | 0.77291493 |
| 121 | MP0002796_impaired_skin_barrier | 0.76847518 |
| 122 | MP0003566_abnormal_cell_adhesion | 0.76658515 |
| 123 | * MP0000920_abnormal_myelination | 0.76045534 |
| 124 | MP0003656_abnormal_erythrocyte_physiolo | 0.74722669 |
| 125 | MP0002998_abnormal_bone_remodeling | 0.74452111 |
| 126 | MP0008469_abnormal_protein_level | 0.72168580 |
| 127 | MP0005595_abnormal_vascular_smooth | 0.71995398 |
| 128 | MP0002078_abnormal_glucose_homeostasis | 0.71172195 |
| 129 | MP0003045_fibrosis | 0.70907119 |
| 130 | MP0003633_abnormal_nervous_system | 0.70870769 |
| 131 | MP0005508_abnormal_skeleton_morphology | 0.70615802 |
| 132 | MP0002909_abnormal_adrenal_gland | 0.69809745 |
| 133 | MP0005390_skeleton_phenotype | 0.69678061 |
| 134 | MP0002254_reproductive_system_inflammat | 0.69324811 |
| 135 | MP0005165_increased_susceptibility_to | 0.68896377 |
| 136 | MP0008961_abnormal_basal_metabolism | 0.68711428 |
| 137 | MP0009115_abnormal_fat_cell | 0.68709370 |
| 138 | MP0001929_abnormal_gametogenesis | 0.68334299 |
| 139 | MP0001764_abnormal_homeostasis | 0.67839859 |
| 140 | MP0005381_digestive/alimentary_phenotyp | 0.67285166 |
| 141 | MP0001542_abnormal_bone_strength | 0.67274394 |
| 142 | MP0004947_skin_inflammation | 0.67071638 |
| 143 | MP0003091_abnormal_cell_migration | 0.66902218 |
| 144 | MP0003303_peritoneal_inflammation | 0.66257878 |
| 145 | MP0000703_abnormal_thymus_morphology | 0.65905611 |
| 146 | MP0001879_abnormal_lymphatic_vessel | 0.65904439 |
| 147 | MP0004381_abnormal_hair_follicle | 0.65841584 |
| 148 | MP0009763_increased_sensitivity_to | 0.65168250 |
| 149 | MP0005257_abnormal_intraocular_pressure | 0.65002206 |
| 150 | MP0009642_abnormal_blood_homeostasis | 0.64190092 |
| 151 | MP0010386_abnormal_urinary_bladder | 0.64089926 |
| 152 | MP0001243_abnormal_dermal_layer | 0.63960158 |
| 153 | MP0009764_decreased_sensitivity_to | 0.63795597 |
| 154 | MP0005448_abnormal_energy_balance | 0.63469450 |
| 155 | MP0000767_abnormal_smooth_muscle | 0.62845895 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement deficiency (HP:0004431) | 4.89876083 |
| 2 | Deep venous thrombosis (HP:0002625) | 4.85264260 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.71690751 |
| 4 | Abnormality of glycolipid metabolism (HP:0010969) | 4.60982167 |
| 5 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.60982167 |
| 6 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.60982167 |
| 7 | Abnormality of macrophages (HP:0004311) | 4.33453739 |
| 8 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 4.20599397 |
| 9 | Myositis (HP:0100614) | 4.19976724 |
| 10 | Xanthomatosis (HP:0000991) | 4.18789916 |
| 11 | Protrusio acetabuli (HP:0003179) | 4.15268619 |
| 12 | Recurrent abscess formation (HP:0002722) | 4.02147948 |
| 13 | Systemic lupus erythematosus (HP:0002725) | 3.96765239 |
| 14 | Abnormality of complement system (HP:0005339) | 3.90735350 |
| 15 | Recurrent bacterial skin infections (HP:0005406) | 3.85428617 |
| 16 | Orchitis (HP:0100796) | 3.80747312 |
| 17 | Absent/shortened dynein arms (HP:0200106) | 3.75800149 |
| 18 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.75800149 |
| 19 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.73735148 |
| 20 | Intrahepatic cholestasis (HP:0001406) | 3.72149399 |
| 21 | Prolonged partial thromboplastin time (HP:0003645) | 3.69332164 |
| 22 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.59264238 |
| 23 | Premature rupture of membranes (HP:0001788) | 3.41349862 |
| 24 | Stomatitis (HP:0010280) | 3.39361539 |
| 25 | Optic neuritis (HP:0100653) | 3.32178533 |
| 26 | Retrobulbar optic neuritis (HP:0100654) | 3.32178533 |
| 27 | Hyperlipoproteinemia (HP:0010980) | 3.31042578 |
| 28 | Mediastinal lymphadenopathy (HP:0100721) | 3.23293728 |
| 29 | Obstructive lung disease (HP:0006536) | 3.21339729 |
| 30 | Chronic obstructive pulmonary disease (HP:0006510) | 3.21339729 |
| 31 | Nasal polyposis (HP:0100582) | 3.15377546 |
| 32 | Abnormality of the nasal mucosa (HP:0000433) | 3.11945860 |
| 33 | Peritonitis (HP:0002586) | 3.10864114 |
| 34 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.10506455 |
| 35 | Neurofibrillary tangles (HP:0002185) | 3.09350277 |
| 36 | Purpura (HP:0000979) | 3.00075489 |
| 37 | Abnormality of the common coagulation pathway (HP:0010990) | 2.87326156 |
| 38 | Increased IgE level (HP:0003212) | 2.86245540 |
| 39 | Amyloidosis (HP:0011034) | 2.84023837 |
| 40 | Abnormal respiratory motile cilium physiology (HP:0012261) | 2.75658857 |
| 41 | Spontaneous hematomas (HP:0007420) | 2.75644794 |
| 42 | Meningitis (HP:0001287) | 2.75261250 |
| 43 | Abnormality of the intrinsic pathway (HP:0010989) | 2.72557704 |
| 44 | Gingivitis (HP:0000230) | 2.71159709 |
| 45 | Glomerulonephritis (HP:0000099) | 2.70139375 |
| 46 | Petechiae (HP:0000967) | 2.69922499 |
| 47 | Recurrent fungal infections (HP:0002841) | 2.69748471 |
| 48 | Skin nodule (HP:0200036) | 2.69609469 |
| 49 | Cerebral inclusion bodies (HP:0100314) | 2.69004997 |
| 50 | Hypercholesterolemia (HP:0003124) | 2.63834654 |
| 51 | Cervical subluxation (HP:0003308) | 2.63769532 |
| 52 | Epidermoid cyst (HP:0200040) | 2.61367369 |
| 53 | Dysostosis multiplex (HP:0000943) | 2.60844703 |
| 54 | Vasculitis (HP:0002633) | 2.60689285 |
| 55 | Gastrointestinal infarctions (HP:0005244) | 2.60169783 |
| 56 | Pulmonary infiltrates (HP:0002113) | 2.59156224 |
| 57 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.57962588 |
| 58 | Mucopolysacchariduria (HP:0008155) | 2.57962588 |
| 59 | Abnormality of dentin (HP:0010299) | 2.55901237 |
| 60 | Recurrent skin infections (HP:0001581) | 2.54750373 |
| 61 | Hypobetalipoproteinemia (HP:0003563) | 2.54315383 |
| 62 | Broad metatarsal (HP:0001783) | 2.53277592 |
| 63 | Nonimmune hydrops fetalis (HP:0001790) | 2.52882420 |
| 64 | Hypoalphalipoproteinemia (HP:0003233) | 2.52107932 |
| 65 | Rhinitis (HP:0012384) | 2.50785862 |
| 66 | Joint hemorrhage (HP:0005261) | 2.48516844 |
| 67 | Beaking of vertebral bodies (HP:0004568) | 2.47208634 |
| 68 | Cellulitis (HP:0100658) | 2.45854407 |
| 69 | Vertebral compression fractures (HP:0002953) | 2.44791387 |
| 70 | Myocardial infarction (HP:0001658) | 2.44219317 |
| 71 | Ketosis (HP:0001946) | 2.44110814 |
| 72 | Mitral stenosis (HP:0001718) | 2.42840638 |
| 73 | Cerebral aneurysm (HP:0004944) | 2.42495143 |
| 74 | Prolonged bleeding time (HP:0003010) | 2.41329042 |
| 75 | Chronic bronchitis (HP:0004469) | 2.38417536 |
| 76 | Pustule (HP:0200039) | 2.36296741 |
| 77 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.34862033 |
| 78 | Vacuolated lymphocytes (HP:0001922) | 2.34852882 |
| 79 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.34171134 |
| 80 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.34171134 |
| 81 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.34171134 |
| 82 | Hypolipoproteinemia (HP:0010981) | 2.33225221 |
| 83 | Hemoptysis (HP:0002105) | 2.32739167 |
| 84 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.30486979 |
| 85 | Hypoglycemic coma (HP:0001325) | 2.30428073 |
| 86 | Hemorrhage of the eye (HP:0011885) | 2.30367500 |
| 87 | Keratoconjunctivitis sicca (HP:0001097) | 2.28683162 |
| 88 | Abnormal respiratory motile cilium morphology (HP:0005938) | 2.28033507 |
| 89 | Abnormal respiratory epithelium morphology (HP:0012253) | 2.28033507 |
| 90 | Epistaxis (HP:0000421) | 2.27619978 |
| 91 | Increased serum ferritin (HP:0003281) | 2.27382514 |
| 92 | Malnutrition (HP:0004395) | 2.26541754 |
| 93 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.25050183 |
| 94 | Infertility (HP:0000789) | 2.24938326 |
| 95 | Urticaria (HP:0001025) | 2.24677290 |
| 96 | Hand muscle atrophy (HP:0009130) | 2.24168703 |
| 97 | Increased cerebral lipofuscin (HP:0011813) | 2.23745075 |
| 98 | Upper limb amyotrophy (HP:0009129) | 2.23576587 |
| 99 | Distal upper limb amyotrophy (HP:0007149) | 2.23576587 |
| 100 | Encephalitis (HP:0002383) | 2.23400793 |
| 101 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 2.20367817 |
| 102 | Inflammation of the large intestine (HP:0002037) | 2.19306611 |
| 103 | Axonal loss (HP:0003447) | 2.19102870 |
| 104 | Emphysema (HP:0002097) | 2.18688641 |
| 105 | Hypergammaglobulinemia (HP:0010702) | 2.18659855 |
| 106 | Gastrointestinal inflammation (HP:0004386) | 2.17927909 |
| 107 | Hepatosplenomegaly (HP:0001433) | 2.17231540 |
| 108 | Protuberant abdomen (HP:0001538) | 2.15973433 |
| 109 | Interstitial pulmonary disease (HP:0006530) | 2.15648736 |
| 110 | Gingival bleeding (HP:0000225) | 2.14565484 |
| 111 | Supranuclear gaze palsy (HP:0000605) | 2.13107043 |
| 112 | Colitis (HP:0002583) | 2.12743042 |
| 113 | Joint stiffness (HP:0001387) | 2.10655064 |
| 114 | Progressive neurologic deterioration (HP:0002344) | 2.08244547 |
| 115 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.08240162 |
| 116 | Recurrent cutaneous fungal infections (HP:0011370) | 2.08240162 |
| 117 | Chest pain (HP:0100749) | 2.08130005 |
| 118 | Gastrointestinal stroma tumor (HP:0100723) | 2.08028867 |
| 119 | Keratoconjunctivitis (HP:0001096) | 2.07169389 |
| 120 | Fat malabsorption (HP:0002630) | 2.07085748 |
| 121 | Nuclear cataract (HP:0100018) | 2.06908433 |
| 122 | Global brain atrophy (HP:0002283) | 2.05020014 |
| 123 | Pulmonary embolism (HP:0002204) | 2.04830184 |
| 124 | Asymmetric septal hypertrophy (HP:0001670) | 2.01066735 |
| 125 | Episodic fever (HP:0001954) | 2.00645392 |
| 126 | Restrictive lung disease (HP:0002091) | 2.00087684 |
| 127 | Ankle contracture (HP:0006466) | 1.97969138 |
| 128 | Hyperammonemia (HP:0001987) | 1.97939877 |
| 129 | J-shaped sella turcica (HP:0002680) | 1.97679738 |
| 130 | Autoimmune thrombocytopenia (HP:0001973) | 1.97573488 |
| 131 | Premature loss of primary teeth (HP:0006323) | 1.97533653 |
| 132 | Increased IgM level (HP:0003496) | 1.93243782 |
| 133 | Nephritis (HP:0000123) | 1.93167040 |
| 134 | Recurrent viral infections (HP:0004429) | 1.92889202 |
| 135 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.92652547 |
| 136 | Polycythemia (HP:0001901) | 1.91879074 |
| 137 | Abnormality of the lower motor neuron (HP:0002366) | 1.91406744 |
| 138 | Acne (HP:0001061) | 1.91108853 |
| 139 | Cardiovascular calcification (HP:0011915) | 1.90738126 |
| 140 | Ovoid vertebral bodies (HP:0003300) | 1.90195174 |
| 141 | Disinhibition (HP:0000734) | 1.89789622 |
| 142 | Tetraparesis (HP:0002273) | 1.89183440 |
| 143 | Abnormality of iron homeostasis (HP:0011031) | 1.87530129 |
| 144 | Retinal atrophy (HP:0001105) | 1.87111976 |
| 145 | Polygenic inheritance (HP:0010982) | 1.86305938 |
| 146 | Spondylolisthesis (HP:0003302) | 1.86146484 |
| 147 | Mutism (HP:0002300) | 1.85697496 |
| 148 | Prolonged neonatal jaundice (HP:0006579) | 1.84049059 |
| 149 | Abnormal ciliary motility (HP:0012262) | 1.84036128 |
| 150 | Thin bony cortex (HP:0002753) | 1.83721844 |
| 151 | Hematochezia (HP:0002573) | 1.83447212 |
| 152 | Leukocytosis (HP:0001974) | 1.82466135 |
| 153 | * Abnormal gallbladder physiology (HP:0012438) | 1.80047757 |
| 154 | * Cholecystitis (HP:0001082) | 1.80047757 |
| 155 | Ketoacidosis (HP:0001993) | 1.78524517 |
| 156 | Biconcave vertebral bodies (HP:0004586) | 1.78282838 |
| 157 | Hypoglycemic seizures (HP:0002173) | 1.76101590 |
| 158 | * Loss of speech (HP:0002371) | 1.75483333 |
| 159 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.74903102 |
| 160 | Vascular calcification (HP:0004934) | 1.73900855 |
| 161 | Ectopia lentis (HP:0001083) | 1.73715465 |
| 162 | Shallow orbits (HP:0000586) | 1.72969535 |
| 163 | Aortic dissection (HP:0002647) | 1.72797015 |
| 164 | Turricephaly (HP:0000262) | 1.70950546 |
| 165 | Short nail (HP:0001799) | 1.70863202 |
| 166 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.70568576 |
| 167 | Neuronal loss in central nervous system (HP:0002529) | 1.70473335 |
| 168 | Buphthalmos (HP:0000557) | 1.70078344 |
| 169 | Increased variability in muscle fiber diameter (HP:0003557) | 1.67478776 |
| 170 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.66454969 |
| 171 | Spontaneous abortion (HP:0005268) | 1.65000200 |
| 172 | Bladder diverticulum (HP:0000015) | 1.64995853 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ERN1 | 4.17542352 |
| 2 | PDK3 | 3.57207977 |
| 3 | PDK4 | 3.57207977 |
| 4 | TRIB3 | 3.34454213 |
| 5 | MAP4K1 | 3.18577049 |
| 6 | TESK1 | 3.09636912 |
| 7 | PRKD3 | 3.04650495 |
| 8 | PDK2 | 2.88088724 |
| 9 | ICK | 2.37187200 |
| 10 | PRPF4B | 2.35908740 |
| 11 | PTK2B | 2.16528741 |
| 12 | MAP3K11 | 2.15865075 |
| 13 | MAPK15 | 1.94438440 |
| 14 | EPHB1 | 1.93062718 |
| 15 | ZAP70 | 1.92748100 |
| 16 | SIK1 | 1.90636549 |
| 17 | IRAK4 | 1.87786472 |
| 18 | GRK6 | 1.87265560 |
| 19 | TAOK1 | 1.78396223 |
| 20 | PKN2 | 1.75940925 |
| 21 | MST1R | 1.75096556 |
| 22 | TIE1 | 1.69801834 |
| 23 | IRAK3 | 1.67006712 |
| 24 | NTRK1 | 1.64388692 |
| 25 | FES | 1.64225953 |
| 26 | JAK3 | 1.59535685 |
| 27 | FGFR4 | 1.59474336 |
| 28 | KDR | 1.58468697 |
| 29 | TAOK2 | 1.55538262 |
| 30 | BCKDK | 1.52654132 |
| 31 | INSRR | 1.48923369 |
| 32 | MAP3K13 | 1.48877114 |
| 33 | DDR2 | 1.47920686 |
| 34 | TGFBR2 | 1.46111644 |
| 35 | PTK6 | 1.45910361 |
| 36 | IKBKE | 1.43909799 |
| 37 | CDC42BPA | 1.43281422 |
| 38 | MET | 1.43109243 |
| 39 | RIPK1 | 1.40818886 |
| 40 | TXK | 1.39676484 |
| 41 | BMX | 1.38228571 |
| 42 | TESK2 | 1.30996115 |
| 43 | CAMKK1 | 1.28670874 |
| 44 | BTK | 1.24416610 |
| 45 | PDGFRA | 1.22999970 |
| 46 | TBK1 | 1.22752506 |
| 47 | IKBKB | 1.22232073 |
| 48 | SYK | 1.12353018 |
| 49 | DYRK1B | 1.10056053 |
| 50 | SIK3 | 1.09988583 |
| 51 | MATK | 1.09226529 |
| 52 | WNK4 | 1.07847882 |
| 53 | MAP3K6 | 1.07563623 |
| 54 | GRK7 | 1.07156326 |
| 55 | NME2 | 1.05343411 |
| 56 | RET | 1.05158265 |
| 57 | ARAF | 1.01367924 |
| 58 | PTK2 | 1.00908418 |
| 59 | FGR | 0.98475324 |
| 60 | CAMK1G | 0.97986391 |
| 61 | EPHA3 | 0.96566093 |
| 62 | LYN | 0.95929130 |
| 63 | JAK1 | 0.93055810 |
| 64 | MAP2K6 | 0.91439845 |
| 65 | SMG1 | 0.90687290 |
| 66 | LCK | 0.90666087 |
| 67 | MAPK7 | 0.90644119 |
| 68 | SIK2 | 0.87480199 |
| 69 | KIT | 0.85529025 |
| 70 | PRKCH | 0.84862960 |
| 71 | FLT3 | 0.84467114 |
| 72 | STK39 | 0.83934340 |
| 73 | STK38 | 0.82118755 |
| 74 | MAP3K3 | 0.79068736 |
| 75 | KSR2 | 0.77379276 |
| 76 | PAK2 | 0.76944521 |
| 77 | PIM2 | 0.76911728 |
| 78 | TTN | 0.76522847 |
| 79 | MAP3K1 | 0.76490294 |
| 80 | MAPKAPK5 | 0.76355318 |
| 81 | TAOK3 | 0.76337901 |
| 82 | PAK6 | 0.75949287 |
| 83 | LATS2 | 0.75008579 |
| 84 | ITK | 0.71695816 |
| 85 | PDPK1 | 0.71040597 |
| 86 | MARK3 | 0.67964325 |
| 87 | HIPK2 | 0.67250022 |
| 88 | MAP2K4 | 0.67214267 |
| 89 | PDK1 | 0.67195723 |
| 90 | IRAK2 | 0.66676563 |
| 91 | TYK2 | 0.66525193 |
| 92 | BMPR2 | 0.66178357 |
| 93 | WNK1 | 0.65926399 |
| 94 | FGFR2 | 0.65485143 |
| 95 | IRAK1 | 0.63574815 |
| 96 | RPS6KC1 | 0.63498778 |
| 97 | RPS6KL1 | 0.63498778 |
| 98 | FER | 0.63401653 |
| 99 | JAK2 | 0.60272249 |
| 100 | PIK3CG | 0.60151806 |
| 101 | CSK | 0.59221937 |
| 102 | RIPK4 | 0.58971109 |
| 103 | ABL2 | 0.58322188 |
| 104 | MAP3K2 | 0.55081405 |
| 105 | CSF1R | 0.53794699 |
| 106 | PAK3 | 0.52458200 |
| 107 | RPS6KA6 | 0.51606467 |
| 108 | CAMK1D | 0.51509848 |
| 109 | PRKD1 | 0.50542906 |
| 110 | DAPK2 | 0.50451865 |
| 111 | MAP2K3 | 0.50347566 |
| 112 | FYN | 0.49630417 |
| 113 | MAP2K2 | 0.49408901 |
| 114 | MAP3K7 | 0.48312147 |
| 115 | MAP2K1 | 0.47319442 |
| 116 | PRKG2 | 0.46883491 |
| 117 | CHUK | 0.46462419 |
| 118 | PDGFRB | 0.45248063 |
| 119 | CAMKK2 | 0.44856560 |
| 120 | TRPM7 | 0.44853157 |
| 121 | TYRO3 | 0.44430682 |
| 122 | MAPK12 | 0.44173844 |
| 123 | MARK2 | 0.43864559 |
| 124 | MOS | 0.42519749 |
| 125 | NEK9 | 0.41892109 |
| 126 | PAK4 | 0.41890549 |
| 127 | MAPK4 | 0.41570341 |
| 128 | BLK | 0.41176887 |
| 129 | MAP3K9 | 0.40583536 |
| 130 | DAPK3 | 0.40280192 |
| 131 | LRRK2 | 0.39988109 |
| 132 | GRK5 | 0.39812568 |
| 133 | SRC | 0.38944457 |
| 134 | PRKD2 | 0.38074897 |
| 135 | TNK2 | 0.37329918 |
| 136 | MAP3K5 | 0.36883861 |
| 137 | RPS6KA2 | 0.36854757 |
| 138 | IGF1R | 0.36742758 |
| 139 | MAPKAPK2 | 0.36468908 |
| 140 | ERBB4 | 0.36311829 |
| 141 | MAP3K14 | 0.36199940 |
| 142 | GSK3A | 0.35972852 |
| 143 | MTOR | 0.35757452 |
| 144 | EEF2K | 0.35080940 |
| 145 | PRKCZ | 0.34298666 |
| 146 | HCK | 0.33806464 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.47118318 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.84566332 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.74879449 |
| 4 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.59151423 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.45913037 |
| 6 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.32589580 |
| 7 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.31657724 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.31303708 |
| 9 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.29446694 |
| 10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.26536409 |
| 11 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.17236926 |
| 12 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.16557630 |
| 13 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.12923549 |
| 14 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.05712818 |
| 15 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.00838099 |
| 16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.99324519 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.97916565 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.97567797 |
| 19 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.90125736 |
| 20 | Tuberculosis_Homo sapiens_hsa05152 | 1.83663762 |
| 21 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.79111508 |
| 22 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.77537594 |
| 23 | Asthma_Homo sapiens_hsa05310 | 1.74527804 |
| 24 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.72438136 |
| 25 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.69885748 |
| 26 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.66706075 |
| 27 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.64628923 |
| 28 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.62352482 |
| 29 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.60086695 |
| 30 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.59258486 |
| 31 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.57690114 |
| 32 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.57549596 |
| 33 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.56858900 |
| 34 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.53884728 |
| 35 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.53019772 |
| 36 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.51593974 |
| 37 | Bile secretion_Homo sapiens_hsa04976 | 1.49975446 |
| 38 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.49947392 |
| 39 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.48354257 |
| 40 | Histidine metabolism_Homo sapiens_hsa00340 | 1.48138229 |
| 41 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.44919940 |
| 42 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.43305689 |
| 43 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.43183036 |
| 44 | Peroxisome_Homo sapiens_hsa04146 | 1.43011297 |
| 45 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.41400620 |
| 46 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.37502173 |
| 47 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.36156970 |
| 48 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.36012617 |
| 49 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.35968519 |
| 50 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.35957553 |
| 51 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.35329801 |
| 52 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.33103200 |
| 53 | Viral myocarditis_Homo sapiens_hsa05416 | 1.32006839 |
| 54 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.31805350 |
| 55 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.31637018 |
| 56 | Influenza A_Homo sapiens_hsa05164 | 1.28658997 |
| 57 | ABC transporters_Homo sapiens_hsa02010 | 1.27346499 |
| 58 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.22846899 |
| 59 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.20512222 |
| 60 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.19876824 |
| 61 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.18307371 |
| 62 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.18245121 |
| 63 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.17419457 |
| 64 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.15263336 |
| 65 | Salmonella infection_Homo sapiens_hsa05132 | 1.09908411 |
| 66 | Prion diseases_Homo sapiens_hsa05020 | 1.09153711 |
| 67 | Measles_Homo sapiens_hsa05162 | 1.08673463 |
| 68 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.08153828 |
| 69 | * Lysosome_Homo sapiens_hsa04142 | 1.07620823 |
| 70 | Other glycan degradation_Homo sapiens_hsa00511 | 1.07395535 |
| 71 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.07071249 |
| 72 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.05100664 |
| 73 | Hepatitis C_Homo sapiens_hsa05160 | 1.04662954 |
| 74 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.02634832 |
| 75 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.01200355 |
| 76 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.00685869 |
| 77 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.97561717 |
| 78 | Retinol metabolism_Homo sapiens_hsa00830 | 0.97505875 |
| 79 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.97023845 |
| 80 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.95851063 |
| 81 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.95360796 |
| 82 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.94804935 |
| 83 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.94543594 |
| 84 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.92626010 |
| 85 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.90994245 |
| 86 | Legionellosis_Homo sapiens_hsa05134 | 0.90056037 |
| 87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.89275018 |
| 88 | Shigellosis_Homo sapiens_hsa05131 | 0.87069065 |
| 89 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.86313584 |
| 90 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.86193630 |
| 91 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.85096913 |
| 92 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.83831550 |
| 93 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.83480429 |
| 94 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.82885748 |
| 95 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.80907149 |
| 96 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.80116422 |
| 97 | Carbon metabolism_Homo sapiens_hsa01200 | 0.80075251 |
| 98 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.79461619 |
| 99 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.78282082 |
| 100 | Platelet activation_Homo sapiens_hsa04611 | 0.77337909 |
| 101 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.76809060 |
| 102 | Hepatitis B_Homo sapiens_hsa05161 | 0.75657944 |
| 103 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.74175224 |
| 104 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.71730432 |
| 105 | Endocytosis_Homo sapiens_hsa04144 | 0.71268629 |
| 106 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.69212865 |
| 107 | Malaria_Homo sapiens_hsa05144 | 0.69076858 |
| 108 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.67473434 |
| 109 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.66272069 |
| 110 | Apoptosis_Homo sapiens_hsa04210 | 0.65716920 |
| 111 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.65433197 |
| 112 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.64909306 |
| 113 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.64829831 |
| 114 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.62908979 |
| 115 | Insulin resistance_Homo sapiens_hsa04931 | 0.62555420 |
| 116 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.61266222 |
| 117 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.59065027 |
| 118 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.58796488 |
| 119 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.58591075 |
| 120 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.58545022 |
| 121 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.58378531 |
| 122 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.57866173 |
| 123 | Amoebiasis_Homo sapiens_hsa05146 | 0.57724089 |
| 124 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.57321643 |
| 125 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.57254437 |
| 126 | Bladder cancer_Homo sapiens_hsa05219 | 0.57142731 |
| 127 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.56518286 |
| 128 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.55457282 |
| 129 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.55450143 |
| 130 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.54709025 |
| 131 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.54354603 |
| 132 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.53660495 |
| 133 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.53390971 |
| 134 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.50009095 |
| 135 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.49285781 |
| 136 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.48219464 |
| 137 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.47813342 |
| 138 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.47423444 |
| 139 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.47285779 |
| 140 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.47110281 |
| 141 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.46761869 |
| 142 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.46399147 |
| 143 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.45652996 |
| 144 | Phagosome_Homo sapiens_hsa04145 | 0.44830800 |
| 145 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.44479243 |
| 146 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.43824163 |
| 147 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.41092973 |
| 148 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.39926677 |
| 149 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.39618568 |
| 150 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.38871287 |
| 151 | Sulfur relay system_Homo sapiens_hsa04122 | 0.38802076 |
| 152 | Galactose metabolism_Homo sapiens_hsa00052 | 0.38329454 |
| 153 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.37875203 |
| 154 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.37740584 |
| 155 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.37691288 |
| 156 | HTLV-I infection_Homo sapiens_hsa05166 | 0.36725821 |
| 157 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.35445019 |
| 158 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.33512722 |
| 159 | Pertussis_Homo sapiens_hsa05133 | 0.33191278 |
| 160 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.32108119 |
| 161 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.31755508 |
| 162 | Lysine degradation_Homo sapiens_hsa00310 | 0.31463198 |
| 163 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.30404517 |
| 164 | Focal adhesion_Homo sapiens_hsa04510 | 0.30022597 |
| 165 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.29418289 |
| 166 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.28618257 |
| 167 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.28602899 |
| 168 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.28013538 |
| 169 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.27813876 |
| 170 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.26724027 |
| 171 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.25786267 |
| 172 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.24757246 |
| 173 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.24692647 |
| 174 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.24669550 |
| 175 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.24393162 |
| 176 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.23876300 |
| 177 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.23553583 |
| 178 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.21909515 |

